NERV Insider Trading Activity and SEC Form 4 Filings
NERV insider trading summary
No open-market insider purchases or sales of Minerva Neurosciences, Inc. (NERV) have been reported on SEC Form 4 in the past 12 months.
Latest NERV insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| May 2, 2023 | Remy Luthringer | CEO | Sell | $14K (3,641 @ $3.76) |
| May 1, 2023 | Geoff Race | President | Sell | $85K (22,082 @ $3.85) |
| May 1, 2023 | Remy Luthringer | CEO | Sell | $91K (23,753 @ $3.85) |
| May 1, 2023 | Frederick W Ahlholm | SVP, CFO and Secretary | Sell | $16K (3,580 @ $4.48) |
| Dec 1, 2021 | David Kupfer | Director | Sell | $49K (55,635 @ $0.88) |
| Dec 16, 2020 | Frederick W Ahlholm | SVP, Chief Accounting Officer | Sell | $5K (1,845 @ $2.64) |
| Dec 16, 2020 | Geoff Race | EVP, CFO & Cbo | Sell | $16K (6,190 @ $2.64) |
| Dec 16, 2020 | Joseph H. Reilly | SVP & Chief Operating Officer | Sell | $9K (3,228 @ $2.64) |
| Dec 16, 2020 | Remy Luthringer | CEO | Sell | $3K (1,300 @ $2.64) |
| Sep 10, 2020 | Heek G Jan Van | Director | Buy | $21K (7,000 @ $2.97) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.